Unlocked Access
FULL SUPPLEMENT: Innovations in Cosmeceuticals: Unlocking the Psychology of Beauty and the Path Toward Rejuvenation
August 2025 | Volume 24 | Issue 8 | Department | 37830s1 | Copyright © August 2025
While evolutionary psychology provides a fundamental understanding of beauty, cultural and personal factors shape aesthetic preferences. Studies indicate that perceptions of beauty vary across geograp...
Read MoreINDIVIDUAL ARTICLE: The Psychology of Beauty: Balancing Nature, Confidence, and Authenticity
August 2025 | Volume 24 | Issue 8 | Supplement Individual Articles | 37831s5 | Copyright © August 2025
Beauty has long played a critical role in human perception, self-image, and social interactions. Rooted in evolutionary psychology, our subconscious attraction to symmetrical features, clear skin...
Read MoreSAIGE II: The Role of Staphylococcus aureus in Skin Barrier Dysfunction and the Development and Severity of Atopic Dermatitis in Young Children
August 2025 | Volume 24 | Issue 8 | Original Article | 810 | Copyright © August 2025
Background: Atopic dermatitis (AD) is a chronic inflammatory skin condition that often manifests in infancy or early childhood, with significant impacts on quality of life and po...
Read MoreChatGPT Improves Readability of Patient Education Materials for Hidradenitis Suppurativa and Psoriasis
August 2025 | Volume 24 | Issue 8 | Features | 828 | Copyright © August 2025
Perceptions and Knowledge of Dermatologic Side Effects of Anti-Cancer Therapies: A Pilot Survey
August 2025 | Volume 24 | Issue 8 | Editorials | e57 | Copyright © August 2025
Commonly Prescribed Hair Loss Treatments Are Rarely Designated as Dermatologic Agents by Insurance Companies
August 2025 | Volume 24 | Issue 8 | Editorials | e53 | Copyright © August 2025
FULL SUPPLEMENT: The New Landscape of Field Cancerization: Proven Efficacy Without Severe Skin Reactions
July 2025 | Volume 24 | Issue 7 | Department | 19911s1 | Copyright © July 2025
Actinic keratosis (AK) is a precancerous lesion that occurs with greatest frequency in individuals aged 60 or older and in men. Given the role of chronic UV exposure in engendering these lesions, they...
Read MoreINDIVIDUAL ARTICLE: Tirbanibulin 1% Ointment: Clinical Trial and Real-World Evidence on Efficacy, Tolerability, Safety, and Patient-Reported Outcomes
July 2025 | Volume 24 | Issue 7 | Supplement Individual Articles | 19912s5 | Copyright © July 2025
Actinic keratosis (AK) is a skin lesion that arises due to chronic sun exposure. Treatment of all AKs is recommended due to their risk of progressing to squamous cell carcinomas (SCCs). Many fiel...
Read MoreINDIVIDUAL ARTICLE: Tirbanibulin 1% Ointment: The Mechanism of Action of a Novel Topical Therapy for Actinic Keratosis
July 2025 | Volume 24 | Issue 7 | Supplement Individual Articles | 19913s13 | Copyright © July 2025
Actinic keratosis (AK) is a common, precancerous skin lesion that may progress to squamous cell carcinoma (SCC). Traditional topical therapies for AKs often require long treatment durations. Thes...
Read MoreINDIVIDUAL ARTICLE: An Algorithm Integrating Acneceuticals Into the Management of Acne Vulgaris
June 2025 | Volume 24 | Issue 6 | Supplement Individual Articles | 08423s13 | Copyright © June 2025
Background: Acne vulgaris is a common, chronic cutaneous disorder with numerous efficacious prescription and procedural treatments. Therapy, however, is hampered by medication in...
Read MoreINDIVIDUAL ARTICLE: The Use of Acneceuticals to Improve Acne Care: Introduction of a New Term and Review of the Literature
June 2025 | Volume 24 | Issue 6 | Supplement Individual Articles | 08422s4 | Copyright © June 2025
Background: Acne is a multifactorial inflammatory skin condition that commonly presents to the dermatology clinic. Treatment generallyinvolves the use of pharmaceuti...
Read MoreUtilization of a Heatmapping Python Program to Visualize Improvements of Skin Hydration After Use of a Moisturizing Lotion or Cream
July 2025 | Volume 24 | Issue 7 | Features | 715 | Copyright © July 2025
Dry skin is both extremely common and an important concern for those who suffer from it. In addition to uncomfortable signs and symptoms, dry skin can be associated with pigmentary changes in ind...
Read MoreFULL SUPPLEMENT: Acneceuticals maximized therapeutic outcomes in a real-world setting
June 2025 | Volume 24 | Issue 6 | Department | 08420s1 | Copyright © June 2025
In this issue:
The Use of Acneceuticals to Improve Acne Care: Introduction of a New Term and Review of the Literature
Acne is the most common cutaneous disease worldwi...
Read MoreINDIVIDUAL ARTICLE: Real-World Clinical Case Series Utilizing Acneceuticals as Monotherapy, Adjunctive, or Maintenance Therapy for Acne Vulgaris
June 2025 | Volume 24 | Issue 6 | Supplement Individual Articles | 08421s19 | Copyright © June 2025
Background: Acne vulgaris is a common, multifactorial inflammatory skin disease for which there are many pharmacologic and procedural interventions. Recent publications have stre...
Read MorePractical Algorithm on Topical Treatment of Flaring Atopic Dermatitis (AD) With or Without Secondary Infection
June 2025 | Volume 24 | Issue 6 | Original Article | 621 | Copyright © June 2025
Acute exacerbations or flares are a key characteristic of atopic dermatitis (AD), often associated with sleep deprivation, as well as experiences of stigmatization, social withdrawal, anxiety, an...
Read MoreRapid Onset of Itch Relief With Tapinarof in Two Phase 3 Trials in Atopic Dermatitis
June 2025 | Volume 24 | Issue 6 | Original Article | 600 | Copyright © June 2025
Background: In the ADORING 1 and 2 phase 3 trials, tapinarof cream 1% once daily (QD) demonstrated significant efficacy and was well tolerated in adults and children down to 2 ye...
Read MoreThiamidol: A Breakthrough Innovation in the Treatment of Hyperpigmentation
June 2025 | Volume 24 | Issue 6 | Original Article | 608 | Copyright © June 2025
Cutaneous hyperpigmentation, including melasma, solar lentigines, and post-inflammatory hyperpigmentation (PIH), results in a significant impact on patients’ quality of life. Unfortunately,...
Read MorePDE4 Inhibitors: Bridging Molecular Insights With Clinical Impact
June 2025 | Volume 24 | Issue 6 | Original Article | 631 | Copyright © June 2025
Phosphodiesterase-4 (PDE4) inhibitors are reshaping the treatment landscape for chronic inflammatory skin diseases by offering effective, non-steroidal options for conditions like psoriasis, atop...
Read MoreExploring the Gut Microbiome's Role in Drug-Induced Photosensitivity: A Need for Deeper Investigation
June 2025 | Volume 24 | Issue 6 | Editorials | e40 | Copyright © June 2025
Social Media as a Catalyst for Health Education and Early Diagnosis of Hidradenitis Suppurativa
June 2025 | Volume 24 | Issue 6 | Editorials | e45 | Copyright © June 2025
© 2025 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
